May 15, 2024 11:08 AM EDTUpdated May 17, 09:57 AM
News Briefing

Adap­ti­m­mune’s debt fi­nanc­ing deal; Tenaya to cut work­ers

ENDPOINTS

Plus, news about Brix­ton Bio­sciences, Mer­ck KGaA, Med­in­cell, Cell­Prothera and GSK:

Adap­ti­m­mune inks up to $125M debt fi­nanc­ing: The biotech gets …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times